Skip to main content
Log in

Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates

  • Originals
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

It has been recently suggested that an acquired deficiency of proteins C and S could contribute to the pathogenesis of meningococcemic purpura fulminans (PF) in children. Our study was designed to measure the levels of antithrombin III (AT III), protein C, and protein S during adult PF and to determine the effects of an early infusion of high doses of AT III concentrates on clinical and biological alterations of PF. We studied five consecutive adult patients with meningococcemia (type B) and PF. The levels of AT III, protein C (antigen and activity), and protein S (total and free) were measured at admission and 24 h and 1 month later. The treatment included in each case: amoxycillin, dobutamine and high doses of AT III concentrates. All patients survived and were discharged without any sequelae. At admission, biological data were consistent with severely depressed protein C and protein S levels and moderately decreased AT III levels, without any discrepancy between protein C antigen and activity. After 24 h, AT III and protein S levels were within normal ranges, whereas protein C levels were still depressed. These data are consistent with the theory of a particular imbalance in the anticoagulant systems during meningococcemic PF, contrasting with the usual findings observed during septic disseminated intravascular coagulation. The possibility must be considered that high doses of one anticoagulant (AT III concentrates) could compensate for the acute decrease in the other (protein C system).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Powars DR, Rogers ZR, Patch MJ, McGehee WG, Francis RB (1987) Purpura fulminans in meningococcemia: association with acquired deficiencies of proteins C and S. N Engl J Med 317:571–572

    Article  PubMed  CAS  Google Scholar 

  2. Bick RL (1982) Clinical relevance of antithrombin III. Semin Thromb Hemost 8:276–287

    Article  PubMed  CAS  Google Scholar 

  3. Stenbjerg S, Pedersen EG, Laursen H (1983) Coagulation fibrinolytic and antithrombin III profiles in severely infected patients. Thromb Res 31:635–640

    Article  Google Scholar 

  4. Emerson TE, Fournel MA, Leach WJ, Redens TB (1987) Protection against disseminated intravascular coagulation and death by antithrombin III in theE. coli endotoxemic rate. Circ Shock 21:1–13

    PubMed  CAS  Google Scholar 

  5. Hauptmann JG, Hassouna HI, Bell TG, Penner JA, Emerson TE (1988) Efficacy of antithrombin III in endotoxin induced disseminated intravascular coagulation. Circ Shock 25:111–122

    Google Scholar 

  6. Blauhut B, Kramar H, Vinazzer H, Bergmann H (1985) Substitution of antithrombin III in shock and disseminated intravascular coagulation. Thromb Res 39:81–89

    Article  PubMed  CAS  Google Scholar 

  7. Odegard OR, Lie M, Abildgaard U (1975) Heparin cofactor activity measured with an amydolytic method. Thromb Res 6:287–294

    Article  PubMed  CAS  Google Scholar 

  8. Nicham F, Ghichaoua JF, Contant G, Martinoli JL (1988) Dosage rapide de l'activité de la protéine C. Ann Biol Clin (Paris) 46:805–808

    CAS  Google Scholar 

  9. Laurell OB (1966) Quantitative estimation of protein by electrophoresis in agarose gel containing antibodies. Ann Biochem 15:45–52

    Article  CAS  Google Scholar 

  10. Comp PC, Doray D, Patton D, Esmon CT (1986) An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 67:504–608

    PubMed  CAS  Google Scholar 

  11. Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Heamatol 17:237–247

    CAS  Google Scholar 

  12. Largo R, Heller V, Straub PW (1976) Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers. Blood 47:991–10002

    PubMed  CAS  Google Scholar 

  13. Griffin GH, Moscher DF, Zimmermann TS, Kleis AJ (1982) Protein C: an antithrombotic protein is reduced in hospitalized patients with intravascular coagulation. Blood 60:261–264

    PubMed  CAS  Google Scholar 

  14. Mannucci PM, Vigano S (1982) Deficiency of protein C, an inhibitor of blood coagulation. Lancet II:463–467

    Article  Google Scholar 

  15. Clouse LH, Comp PC (1986) The regulation of homeostasis. The protein C system. N Engl J Med 314:1298–1304

    Article  PubMed  CAS  Google Scholar 

  16. Marlar RA, Endres-Brooks J, Miller C (1985) Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 66:59–63

    PubMed  CAS  Google Scholar 

  17. Vandermeer FJ, Broekmans AW, Bertina RM, Briet B (1985) Protein C activity and antigen levels in patients with intravascular coagulation. Scand J Clin Lab Invest 45:133

    Google Scholar 

  18. Fourrier F, Lestavel P, Leclerc L, Chopin C, Marey A, Goudemand J (1987) Traitement des coagulations intravasculaires disséminées septiques par l'antithrombine III. Reanim Soins Intens Med Urgence 3:281 (abstr)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fourrier, F., Lestavel, P., Chopin, C. et al. Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med 16, 121–124 (1990). https://doi.org/10.1007/BF02575306

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02575306

Key words

Navigation